Isolation and Characterization of Chromosome-gain and Increase-in-ploidy Mutants in Yeast
Overview
Authors
Affiliations
We have developed a colony papillation assay for monitoring the copy number of genetically marked chromosomes II and III in Saccharomyces cerevisiae. The unique feature of this assay is that it allows detection of a gain of the marked chromosomes even if there is a gain of the entire set of chromosomes (increase-in-ploidy). This assay was used to screen for chromosome-gain or increase-in-ploidy mutants. Five complementation groups have been defined for recessive mutations that confer an increase-in-ploidy (ipl) phenotype, which, in each case, cosegregates with a temperature-sensitive growth phenotype. Four new alleles of CDC31, which is required for spindle pole body duplication, were also recovered from this screen. Temperature-shift experiments with ipl1 cells show that they suffer severe nondisjunction at 37 degrees. Similar experiments with ipl2 cells show that they gain entire sets of chromosomes and become arrested as unbudded cells at 37 degrees. Molecular cloning and genetic mapping show that IPL1 is a newly identified gene, whereas IPL2 is allelic to BEM2, which is required for normal bud growth.
De-regulation of aurora kinases by oncogenic HPV; implications in cancer development and treatment.
Oladipo K, Parish J Tumour Virus Res. 2025; 19:200314.
PMID: 39923999 PMC: 11867274. DOI: 10.1016/j.tvr.2025.200314.
A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma.
Subramani B, Conway P, Al-Khinji A, Zhang K, Pandey R, Mahadevan D Cancers (Basel). 2025; 16(24.
PMID: 39766156 PMC: 11674227. DOI: 10.3390/cancers16244257.
Damodaran A, Gavard O, Gagne J, Rogalska M, Behera A, Mancini E J Biol Chem. 2024; 301(1):108000.
PMID: 39551136 PMC: 11732490. DOI: 10.1016/j.jbc.2024.108000.
Chen M, Zhu H, Li J, Luo D, Zhang J, Liu W Ann Med. 2024; 56(1):2282184.
PMID: 38738386 PMC: 11095293. DOI: 10.1080/07853890.2023.2282184.
Binding selectivity analysis of AURKs inhibitors through molecular dynamics simulation studies.
Alharthy R, Fatima G, Yousaf N, Iqbal M, Sattar S, Alanzi A PLoS One. 2023; 18(12):e0295741.
PMID: 38113210 PMC: 10729953. DOI: 10.1371/journal.pone.0295741.